4//SEC Filing
Turner William D. 4
Accession 0001209191-22-023656
CIK 0001290149other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:12 PM ET
Size
14.5 KB
Accession
0001209191-22-023656
Insider Transaction Report
Form 4
Turner William D.
Chief Reg & Tech Ops Officer
Transactions
- Sale
Common Stock
2022-04-05$37.09/sh−100$3,709→ 0 total - Exercise/Conversion
Common Stock
2022-04-06$12.05/sh+6,347$76,481→ 6,347 total - Sale
Common Stock
2022-04-06$37.25/sh−6,347$236,409→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-05+100→ 0 totalExercise: $12.05Exp: 2030-08-04→ Common Stock (100 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-06+6,347→ 0 totalExercise: $12.05Exp: 2030-08-04→ Common Stock (6,347 underlying) - Exercise/Conversion
Common Stock
2022-04-05$12.05/sh+100$1,205→ 100 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2021. The Reporting Person is subject to a Lock-Up Letter Agreement that expires on April 26, 2022. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
- [F2]On August 4, 2021, the option vested as to 25% of the total shares granted on August 4, 2020, with the remaining shares from that grant vesting in equal monthly installments over the following 36 months, with 100% of the total shares vested on August 4, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Sierra Oncology, Inc.
CIK 0001290149
Entity typeother
Related Parties
1- filerCIK 0001819688
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:12 PM ET
- Size
- 14.5 KB